Literature DB >> 17296583

New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.

Anne Murati, José Adélaïde, Benoît Quilichini, Virginie Rémy, Danielle Sainty, Anne-Marie Stoppa, Philippe Bernard, Sylviane Olschwang, Daniel Birnbaum, Max Chaffanet, Marie-Joëlle Mozziconacci.   

Abstract

The t(8;16)(p11;p13) translocation, associated with poor prognosis acute monocytic leukemia, fuses MYST3 on chromosome region 8p11 to CBP on chromosome region 16p13. Two types of MYST3-CBP and CBP-MYST3 fusion transcripts have been identified in patients. We describe two new types of MYST3-CBP transcripts and a new primer set.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17296583     DOI： 10.3324/haematol.10744

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  2 in total

1.  [Acute myeloid leukemia and translocation (8; 16) (p11; p13), the first Moroccan case of a distinct clinical-biological entity].

Authors:  Adiba Bakkali; Mouna Lemchaheb; Nezha Had; Hind Dehbi; Said Benchekroun; Asma Quessar
Journal:  Pan Afr Med J       Date:  2015-06-23

2.  Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma.

Authors:  Andrew R Conery; Richard C Centore; Adrianne Neiss; Patricia J Keller; Shivangi Joshi; Kerry L Spillane; Peter Sandy; Charlie Hatton; Eneida Pardo; Laura Zawadzke; Archana Bommi-Reddy; Karen E Gascoigne; Barbara M Bryant; Jennifer A Mertz; Robert J Sims
Journal:  Elife       Date:  2016-01-05       Impact factor: 8.140
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.